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412 The Journal of Thoracic and CardioObjective: Tremendous strides have been made in the outcomes for hypoplastic left
heart syndrome and other functional single-ventricle malformations over the past 25
years. This progress relates primarily to improvements in survival for patients
undergoing the Norwood procedure. Previous reports on risk factors have been on
smaller groups of patients or collected over relatively long periods of time, during
which management has evolved. We analyzed our current results for the Norwood
procedure with attention to risk factors for poor outcome.
Methods: A single-institution review of all patients undergoing a Norwood proce-
dure for a single-ventricle malformation from May 1, 2001, through April 30, 2003,
was performed. Patient demographics, anatomy, clinical condition, associated
anomalies, operative details, and outcomes were recorded.
Results: Of the 111 patients, there were 23 (21%) hospital deaths. Univariate
analysis revealed noncardiac abnormalities (genetic or significant extracardiac di-
agnosis, P  .0018), gestational age (P  .03), diagnosis of unbalanced atrioven-
tricular septal defect (P  .017), and weight of less than 2.5 kg (P  .0072) to be
related to hospital death. On multivariate analysis, only weight of less than 2.5 kg
and noncardiac abnormalities were found to be independent risk factors. Patients
with either of these characteristics had a hospital survival of 52% (12/23), whereas
those at standard risk had a survival of 86% (76/88).
Conclusions: Although improvements in management might have lessened the
effect of some of the traditionally reported risk factors related to variations in the
cardiovascular anatomy, noncardiac abnormalities and low birth weight remain as a
future challenge for the physician caring for the patient with single-ventricle
physiology.
Until only a quarter century ago, hypoplastic left heart syndrome (HLHS)was a uniformly fatal condition. Without early intervention, 95% of af-fected infants died within the first month of life.1 The outlook has improved
dramatically since Norwood and colleagues2 reported the first successful staged
palliative reconstructive operations for infants with HLHS in 1983 and Bailey and
associates3 introduced cardiac transplantation for the disease in 1986. However,
despite improvements in survival, HLHS continues to be the most common anomaly
resulting in death within the first year of life in the United States.4 Most of the
mortality associated with staged repair occurs during the first stage, the Norwood
vascular Surgery ● February 2006
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factors associated with higher mortality could lead to better
identification of those infants more likely to benefit from
transplantation rather than staged repair.
Many authors have previously reported risk factors for
the Norwood procedure. Despite these numerous reports,
there exists no consensus on which risk factors are signifi-
cant. Forbess and coworkers5 found lower preoperative pH
to be a significant risk factor for stage I mortality, whereas
in a previous report6 our group found no increased risk.
Initial operations after 14 or 30 days have both been re-
ported as a risk factor,6-8 whereas others have found no
increased risk for those infants operated on after 14 days of
life.9 The data are similarly ambiguous for fetal diagno-
sis,10-13 anatomic subtype of HLHS,5,6,8,10,14,15 lower oper-
ative weight,5,6,8,10,16-18 smaller ascending aortic diame-
ter,5,6,16,17,19-21 longer circulatory arrest6,11,17,20 or cardio-
pulmonary bypass (CPB) time,11,17,21 noncardiac congenital
anomalies,7,16,22,23 and the presence of moderate-to-severe
tricuspid regurgitation before the operation.5,17,19,24 In ad-
dition to these risk factors, 3 authors have reported a higher
risk of mortality associated with obstructed pulmonary ve-
nous return.7,8,22,25
Many of these previously reported risk factors were
derived from small cohorts of patients or collected over
relatively long periods of time, during which management
patterns have evolved. These factors might account for the
level of disparity among risk factors described in the liter-
ature. This report describes our recent experience with the
Norwood procedure for palliation of HLHS and other func-
tional single ventricle (FSV) malformations, with a focus on
identifying relevant risk factors in the current era.
Patients and Methods
Study Design
A single-center retrospective review of the medical records of
children undergoing a Norwood procedure for the correction of
HLHS or other FSV malformations at the C.S. Mott Children’s
Hospital of the University of Michigan Health Systems from May
1, 2001, through April 30, 2003, was performed. Approval was
obtained from the institutional review board before initiation of the
study.
The study hypothesis was that because of improvements in
operative technique and perioperative management, many of the
traditional risk factors previously reported for the Norwood pro-
Abbreviations and Acronyms
CPB  cardiopulmonary bypass
DHCA deep hypothermic circulatory arrest
FSV  functional single ventricle
HLHS  hypoplastic left heart syndrome
RCP  regional cerebral perfusioncedure have been overcome.
The Journal of ThoraciPatient Population
Between May 1, 2001, and April 30, 2003, 111 infants underwent
a Norwood procedure for HLHS or other FSV malformations. The
demographic data that were collected included gestational age at
birth, age at initial operation, weight at operation, sex, race, cardiac
anatomy, noncardiac diagnoses, and fetal diagnosis. Surrogates for
condition at presentation included history of cardiac arrest or
seizures, the lowest pH, and the peak creatinine levels. Preopera-
tive pH and creatinine levels estimated adequacy of resuscitation
and immediate preoperative condition. Also noted were the need
for balloon atrial septostomy and the presence of pulmonary ve-
nous obstruction, as defined by significant hypoxemia in conjunc-
tion with radiographic evidence of pulmonary edema and an intact
or nearly intact atrial septum confirmed by means of Doppler
echocardiography and direct surgical or pathologic inspection.
Echocardiographic parameters, including cardiac valve sizes and
functions, aortic size and the presence of antegrade flow, and
ventricular function, were all collected. Operative parameters in-
cluded time in the operating room, deep hypothermic circulatory
arrest (DHCA) or regional cerebral perfusion (RCP) time, CPB
time, and shunt type and size. Postoperative parameters included
time to chest closure and extubation, days in the intensive care
unit, and days in the hospital. Time of follow-up and continuation
to hemi-Fontan or Fontan procedures were also recorded. A de-
tailed list of the potentially significant factors that were recorded is
included in Appendix 1. Hospital survival was the primary
outcome.
Surgical Technique
The technique used for the first stage of reconstruction was a
classic Norwood procedure, as initially described by Pigott and
associates.26 Important modifications, including the manner of the
proximal aortic anastomosis, technique and extent of the arch
reconstruction, and the use of smaller shunts, have been previously
detailed in a publication from our group.22 One hundred five of the
patients received a systemic–to–pulmonary artery shunt, of which
66% (69/105) were 3.5 mm, 31% (33/105) were 4.0 mm, and 3%
(3/105) were 3.0 mm. Six patients (median weight, 2.2 kg; range,
1.7-3.2 kg) received a right ventricle–to–pulmonary artery shunt
ranging in size from 4.0 to 5.0 mm.
Statistical Analysis
Normally distributed data are expressed as means  standard
deviation. Nonnormal data are expressed as medians and ranges.
Dichotomous variables were analyzed with the Fisher exact test,
and continuous variables were subjected to the Student t test.
Wilcoxon rank sum testing was used for nonnormally distributed
data.
Results
Patient Population
Of the 111 patients, there were 71 (64.0%) male and 40
(36.0%) female patients. Mean age at the time of the oper-
ation was 9  5 days. Twelve (10.8%) patients were more
than 14 days old at the time of their initial operation, and 2
(1.8%) of these patients were more than 30 days old. Me-
dian weight at the time of the operation was 3.2 kg (range,
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at the time of their initial operations. The median gestational
age at birth was 39 weeks (range, 33.0-42.5 weeks). There
were 90 (81%) white, 8 (7%) African-American, 6 (5%)
Hispanic, and 7 (6%) “other” or “unknown” infants. One
hundred (90%) of 111 patients were given diagnoses of
HLHS, as defined by a right ventricle–dependent circula-
tion with aortic atresia or hypoplasia. Five (4%) patients had
tricuspid atresia, 4 (4%) had a double-inlet left ventricle,
and 2 (2%) had transposition of the great arteries with an
FSV. Of these patients, 3 (3%) had heterotaxy. Overall,
there were 101 (91%) patients with a functional single right
ventricle, whereas 10 (9%) had a functional single left
ventricle.
Of the 100 patients with HLHS, there were 36 (36%)
with aortic atresia and mitral atresia, 23 (23%) with aortic
stenosis and mitral stenosis, 20 (20%) with aortic atresia and
mitral stenosis, 1 (1%) with aortic stenosis and mitral atre-
sia, 10 (10%) with a common atrioventricular valve orifice,
and 10 (10%) with double-outlet right ventricle. The median
ascending aorta size was 3.3 mm (range, 1.40-8.60 mm).
Antegrade aortic flow was seen in 49 (42%) patients.
Twelve (11%) patients were identified as dysmorphic,
and 34 (31%) patients underwent genetic analysis. Eleven
(10%) patients were found to have abnormal chromosomes
or a named genetic syndrome (Table 1). Ten (9%) patients
had significant acquired or congenital extracardiac diag-
noses (Table 2).
There were 68 (61%) patients in whom a fetal diagnosis
was attained. The median lowest preoperative pH was 7.42
(range, 7.25-7.53), and the median preoperative pH was
7.42 (range, 7.25-7.53). The median peak creatinine level
was 0.80 mg/dL (range, 0.40-5.50 mg/dL), and the median
preoperative creatinine level was 0.70 mg/dL (range, 0.40-
3.90 mg/dL). No patients had a history of cardiac arrest
before the initial operation, but 6 (5%) had a history of
TABLE 1. Chromosomal abnormalities-syndromes
Anomaly n
Turner 2
Indeterminate* 2
Costello 1
Jacobsen 1
VACTERL 1
Alagille 1
Ritscher-Schinzel 1
McKusick-Kauffman 1
In(3)(p11.2q25.1) 1
VACTERL, vertebral/anal/cardiothoracic/tracheoesophageal fistula/renal/
limb association. *Believed by genetics consultation to be significantly
syndromic without specific diagnosis.seizures. Six (5%) patients required balloon atrial septos-
414 The Journal of Thoracic and Cardiovascular Surgery ● Febrtomy before the Norwood procedure to relieve pulmonary
venous obstruction.
Median time in the operating room was 205 minutes (range,
149-525 minutes). Seventy-five (68%) patients underwent
DHCA, whereas RCP was used in the remaining 36 (32%)
patients. Median DHCA time was 37 minutes (range, 24-68
minutes). Median RCP time was 39 minutes (range,
30-69 minutes). Median CPB time was 96 minutes (range,
59-308 minutes).
Chest closure was performed after a median of 7 days
(range, 1-15 days), and patients were extubated after a
median of 7 days (range, 2-46 days). The median number of
days in the intensive care unit for survivors was 9 (range,
3-87 days), and the average length of hospital stay for
survivors was 21 days (range, 8-148 days). Median length
of follow-up was 17 months (range, 0.5-33 months), with 71
(64%) patients undergoing stage II palliation. Of these 71
patients, 30 (27%) have gone on to a Fontan procedure.
Hospital Survival and Risk Factors
The overall hospital survival was 79% (88/111 patients).
The most common cause of death was low cardiac output in
the immediate postoperative period in 39% (9/23) of pa-
tients, followed by unexpected arrest in patients seemingly
making an unremarkable recovery in 22% (5/23). Other
cardiorespiratory causes of death included high pulmonary
vascular resistance in a patient with a history of obstructed
pulmonary venous return (n  1), refractory arrhythmia
(n  1), severe native aortic insufficiency (n  1), severe
neoaortic insufficiency (n  1), and severe tricuspid regur-
gitation (n 1). Noncardiac causes included sepsis (n 1),
necrotizing enterocolitis (n  1), retroperitoneal hemor-
rhage caused by bladder perforation (n  1), and intracra-
nial hemorrhage caused by cerebral aneurysm (n  1).
Table 3 shows the variables that could not be shown to
have an effect on hospital survival. Univariable analysis
revealed that noncardiac abnormalities, including genetic
abnormalities or significant extracardiac malformations
(P  .0018), gestational age at operation (P  .03), diag-
nosis of unbalanced atrioventricular septal defect (P 
.017), and weight of less than 2.5 kg (P  .0072) were
TABLE 2. Extracardiac diagnoses
Diagnosis n
Renal dysplasia-insufficiency 3
Intracranial
Absent corpus callosum 1
Cerebrovascular accident 1
Cerebral aneurysm 1
Biliary atresia 1
Pulmonary dysplasia 1
Multiple 2significantly related to hospital death (Table 4).
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multivariable analysis proved to be weight of less than 2.5
kg at the time of the operation (P  .0098; odds ratio, 7.0)
and noncardiac congenital abnormalities (P  .032; odds
ratio, 6.0; Table 5). The presence of either weight of less
than 2.5 kg or a noncardiac diagnosis conveyed a hospital
survival of 52% (12/23) compared with 86% (76/88) for
infants at standard risk.
Discussion
Operative survival after the Norwood procedure, the first
stage in surgical palliation for HLHS and other conditions
resulting in FSV physiology, has improved steadily since
the early 1980s because of advancements in perioperative
care and improvements in operative procedures. Mahle and
colleagues8 at the Children’s Hospital of Philadelphia re-
ported an improvement in hospital survival from 56.2%
from 1984 through 1989 to 71.3% from 1995 through 1998
and 77.4% during 1998. At The Hospital for Sick Children
in Toronto, hospital survival improved from 41% from 1990
through 1993 to 61% from 1994 through 1997 and 81%
from 1998 through 2000.16 Hospital survival from 1992
through 1996 at the Children’s Hospital of Wisconsin was
53%, whereas it reached 93% from 1996 through 2001.21
We have likewise experienced significant improvements at
TABLE 3. Factors not achieving statistical significance
Survi
Fetal diagnosis 61% (52/
Gestational age 35 wk 0% (0/8
Sex 60 M/
Age 30 d 1% (1/8
Aortic atresia 58% (58/
Obstructed pulmonary venous return 7% (6/8
Median bypass time (min) 93.5 (59-
Median DHCA or RCP time (min) 36 (24-
RVPA conduit 3% (3/8
Median MBTS diameter (mm) 3.5 (3.0
Median lowest preoperative Ph 7.34 (7.1
Median ascending aortic size (mm) 3.25 (1.4
Median degree of TR (0-4) 1 (0-3
DHCA, Deep hypothermic circulatory arrest; RCP, regional cerebral perfus
shunt; TR, tricuspid regurgitation.
TABLE 4. Univariable analysis
Survi
Noncardiac anomaly 9% (8/
Weight 2.5 kg 5% (4/
HLHS with CAVV (unbalanced AVSD) 6% (5/
Gestational age (wk) 40.1 (35
Weight (kg) 3.3 (1.9HLHS, Hypoplastic left heart syndrome; CAVV, common atrioventricular valve; A
The Journal of Thoracithe University of Michigan since first performing the Nor-
wood procedure for HLHS in 1983. Meliones and cowork-
ers27 reported a 46% thirty-day survival for patients oper-
ated on between 1983 and 1989. From 1990 through 1997,
hospital survival had improved to 76%, as reported by
Lloyd and Bove.7,22
In this analysis we found that many of the previously
reported risk factors related to cardiovascular anatomy ap-
pear to have been minimized in the current era. The most
commonly reported factors, including obstructed pulmonary
venous return, ascending aortic diameter, anatomic subtype
of HLHS, age at initial operation, preoperative pH, CPB
time or operative time, and fetal diagnosis, could not be
shown to have a significant effect on survival. Perhaps most
surprising is the fact that obstructed pulmonary venous
return did not reach significance. The most obvious expla-
nation would be the limited sample size. However, recent
advances in postoperative management, such as inhaled
nitric oxide and sildenafil, might also have an effect. Per-
haps most importantly, the objective of this study was to
evaluate risk factors for hospital survival in the current era.
The failure to define obstructed pulmonary venous return as
a risk factor for hospital survival should not be misinter-
preted to mean that it does not have a significant effect on
the ultimate outcome of the patient with FSV. Underscoring
Mortality P value
70% (16/23) .42
9% (2/23) .76
11 M/12 F .07
4% (1/23) .37
39% (9/23) .11
9% (2/23) .77
110 (65-308) .07
40.5 (30-49) .57
17% (4/23) NS
3.5 (3.0-4.0) NS
6) 7.34 (7.20-7.44) .67
3.9 (1.4-8.6) .52
1 (0-3) NS
VPA, right ventricle to pulmonary artery; MBTS, modified Blalock-Taussig
Mortality P value
35% (8/23) .0018
17% (4/23) .0072
22% (5/23) .017
) 39.4 (33.3-44.6) .03
3.0 (1.3-4.5) .04vor
85)
4)
28 F
8)
88)
7)
242)
68)
8)
-4.0)
1-7.4
-8.2)
)
ion; Rvor
88)
88)
88)
-45.6
-4.5)VSD, atrioventricular septal defect.
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of undetermined cause, 1 patient whose Fontan procedure
was delayed because of marginal pulmonary vascular resis-
tance, and 1 patient who is not a Fontan candidate and will
ultimately require a cardiac transplantation because of pul-
monary vascular obstructive disease.
Weight of less than 2.5 kg and noncardiac diagnoses
continue to be significant risk factors for hospital survival
for patients with HLHS or other FSV conditions. Although
noncardiac anomalies might be more difficult to affect,
recent advances might improve the survivals for the low-
birth-weight FSV patient. The management of pulmonary
blood flow is problematic in these smallest of patients. The
traditional 3.5-mm modified Blalock-Taussig shunt results
in pulmonary overcirculation and systemic malperfusion.
The 3.0-mm graft leaves little room for technical error at the
anastomoses and is potentially at increased risk of throm-
bosis. The recent renewed interest in the right ventricle–to–
pulmonary artery conduit for the Norwood procedure might
be a solution for these low-birth-weight patients. Although
challenges remain, ongoing advances in preoperative, intra-
operative, and postoperative management continue to im-
prove the outlook for the patient with FSV.
Although this is a relatively large cohort of patients, it is
possible that other risk factors might have been identified
with a larger sample size. However, it is important to note
that several of the previously identified risk factors have
been identified from small groups of patients, suggesting
that at a minimum, the effect of many of these risk factors
has been lessened.
An analysis of the effect of DHCA versus RCP could not
be performed. Data are listed and analyzed as total DHCA
or RCP time. The study subjects are also participating in an
ongoing randomized, prospective, evaluator-blinded trial.
Because there were personnel common to both this article
and to the blinded portion of the study, we were unable to
perform this analysis without compromising the randomized
trial.
This cohort is a heterogeneous population of patients
undergoing a common operation. However, the numbers of
patients are too small to perform meaningful subgroup
analysis, which leaves the possibility that certain risk factors
TABLE 5. Multivariable analysis
Survivor Mortality P value Odds ratio
Weight 2.5 kg 5% (4/88) 17% (4/23) .0098 7.0
Noncardiac
anomaly
9% (8/88) 35% (8/23) .032 6.0
HLHS with CAVV
(unbalanced AVSD)
6% (5/88) 22% (5/23) .083 3.7
HLHS, Hypoplastic left heart syndrome; CAVV, common atrioventricular
valve; AVSD, atrioventricular septal defect.might apply to individual diagnostic groups.
416 The Journal of Thoracic and Cardiovascular Surgery ● FebrThe primary outcome for this study was hospital sur-
vival, and the follow-up is of an intermediate length. Patient
characteristics, which might act as risk factors for late
survival, cannot be defined.
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Appendix 1.
Comprehensive list of factors analyzed
Demographics
Age
Weight
Gestational age at birth
Gestational age at operation
Sex
Race
Primary cardiac diagnosis
Other cardiac diagnoses
Other noncardiac diagnoses
Anatomic subtype of hypoplastic left heart syndrome (aortic
stenosis-atresia, mitral stenosis-atresia)
Morphologic right versus left ventricle
Dysmorphic by physical examination
Chromosomal abnormality
Genetic syndrome
The Journal of ThoraciPreoperative factors
Fetal diagnosis
History of cardiopulmonary arrest
Lowest preoperative pH
Immediate preoperative pH
Peak preoperative creatinine
Immediate preoperative creatinine
History of seizures
Obstructed pulmonary venous return
Cause of obstructed pulmonary venous return
Need for balloon atrial septostomy
Echocardiographic data
Aortic valve diameter and Z value
Ascending aortic (at sinotubular junction) diameter and Z value
Midtransverse arch diameter and Z value
Mitral valve diameter and Z value
Tricuspid valve diameter and Z value
Ventricular function
Antegrade aortic flow
Degree of tricuspid regurgitation
Degree of mitral regurgitation
Degree of aortic regurgitation
Degree of pulmonary regurgitation
Degree of tricuspid regurgitation
Operative data
Total operative time
Cardiopulmonary bypass time
Deep hypothermic circulatory arrest or region cerebral perfu-
sion time
Shunt type
Shunt size
Hospital course
Time to chest closure
Time to initial extubation
Days to initial intensive care unit discharge
Days to hospital discharge
Hospital survival
Follow-up
Length of follow-up
Progression to hemi-Fontan procedure
Progression to Fontan procedure
Dead-alive
Cause of death
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